METAFORA BIOSYSTEMS;UNIVERSITE DE MONTPELLIER;CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE;INSERM (INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE)
发明人:
TOUHAMI, JAWIDA,E, GUANGQI,GIOVANNINI, DONATELLA,ROBERT, BRUNO,SEVESTRE, SAMUEL,BUSSON, MURIEL,BATTINI, JEAN-LUC,PETIT, VINCENT,SITBON, MARC
申请号：
CA3000884
公开号：
CA3000884A1
申请日:
2016.10.05
申请国别(地区):
CA
年份:
2017
代理人:
摘要：
The present invention relates to methods for diagnosing pancreatic cancer, wherein said methods comprises measuring the expression level of ASCT1 and/or ASCT2 and/or XPR1. The present invention further relates to a RBD ligand coupled to at least one contrast agent, that may be used as a probe for medical imaging.
